Works by Sherman, Matthew L.

Results: 19

A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.

Published in:

2019

By:

Voss, Martin H.;
Bhatt, Rupal S.;
Vogelzang, Nicholas J.;
Fishman, Mayer;
Alter, Robert S.;
Rini, Brian I.;
Beck, J. Thaddeus;
Joshi, Monika;
Hauke, Ralph;
Atkins, Michael B.;
Burgess, Earle;
Logan, Theodore F.;
Shaffer, David;
Parikh, Rahul;
Moazzam, Nauman;
Zhang, Xiaosha;
Glasser, Chad;
Sherman, Matthew L.;
Plimack, Elizabeth R.

Publication type:

journal article

A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Published in:

2016

By:

Jimeno, Antonio;
Posner, Marshall R.;
Wirth, Lori J.;
Saba, Nabil F.;
Cohen, Roger B.;
Popa, Elizabeta C.;
Argiris, Athanassios;
Grossmann, Kenneth F.;
Sukari, Ammar;
Wilson, Dawn;
Zhang, Xiaosha;
Sun, Jade;
Glasser, Chad;
Attie, Kenneth M.;
Sherman, Matthew L.;
Pandya, Susan S.;
Weiss, Jared

Publication type:

journal article

Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells.

Published in:

Journal of Cellular Physiology, 1988, v. 134, n. 3, p. 429, doi. 10.1002/jcp.1041340314

By:

Sherman, Matthew L.;
Shafman, Timothy D.;
Kufe, Donald W.

Publication type:

Article

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.

Published in:

2005

By:

Larson, Richard A;
Sievers, Eric L;
Stadtmauer, Edward A;
Löwenberg, Bob;
Estey, Elihu H;
Dombret, Hervé;
Theobald, Matthias;
Voliotis, Dimitris;
Bennett, John M;
Richie, Maria;
Leopold, Lance H;
Berger, Mark S;
Sherman, Matthew L;
Loken, Michael R;
van Dongen, Jacques J M;
Bernstein, Irwin D;
Appelbaum, Frederick R

Publication type:

journal article

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence.

Published in:

Cancer (0008543X), 2005, v. 104, n. 7, p. 1442, doi. 10.1002/cncr.21326

By:

Richard A. Larson;
Eric L. Sievers;
Edward A. Stadtmauer;
Bob Löwenberg;
Elihu H. Estey;
Hervé Dombret;
Matthias Theobald;
Dimitris Voliotis;
John M. Bennett;
Maria Richie;
Lance H. Leopold;
Mark S. Berger;
Matthew L. Sherman;
Michael R. Loken;
Jacques J. M. van Dongen;
Irwin D. Bernstein;
Frederick R. Appelbaum

Publication type:

Article

Multiple-dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA-IgG1), a novel erythropoietic agent, in healthy postmenopausal women.

Published in:

Journal of Clinical Pharmacology, 2013, v. 53, n. 11, p. 1121, doi. 10.1002/jcph.160

By:

Sherman, Matthew L.;
Borgstein, Niels G.;
Mook, Louisa;
Wilson, Dawn;
Yang, Yijun;
Chen, Nianhang;
Kumar, Ravindra;
Kim, Kenneth;
Laadem, Abderrahmane

Publication type:

Article

Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study of ACE-011 (ActRIIA-IgG1) in Postmenopausal Women.

Published in:

Journal of Bone & Mineral Research, 2009, v. 24, n. 4, p. 744, doi. 10.1359/jbmr.081208

By:

Ruckle, Jon;
Jacobs, Mark;
Kramer, William;
Pearsall, Amelia E.;
Kumar, Ravindra;
Underwood, Kathryn W.;
Seehra, Jasbir;
Yang, Yijun;
Condon, Carolyn H.;
Sherman, Matthew L.

Publication type:

Article

Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study.

Published in:

Oncologist, 2021, v. 26, n. 11, p. e2053, doi. 10.1002/onco.13917

By:

Zalcberg, John R.;
Heinrich, Michael C.;
George, Suzanne;
Bauer, Sebastian;
Schöffski, Patrick;
Serrano, César;
Gelderblom, Hans;
Jones, Robin L.;
Attia, Steven;
D'Amato, Gina;
Chi, Ping;
Reichardt, Peter;
Somaiah, Neeta;
Meade, Julie;
Reichert, Vienna;
Shi, Kelvin;
Sherman, Matthew L.;
Ruiz‐Soto, Rodrigo;
von Mehren, Margaret;
Blay, Jean‐Yves

Publication type:

Article

A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma.

Published in:

Oncologist, 2019, v. 24, n. 2, p. 161, doi. 10.1634/theoncologist.2018-0654

By:

Abou‐Alfa, Ghassan K.;
Miksad, Rebecca A.;
Tejani, Mohamedtaki A.;
Williamson, Stephen;
Gutierrez, Martin E.;
Olowokure, Olugbenga O.;
Sharma, Manish R.;
El Dika, Imane;
Sherman, Matthew L.;
Pandya, Shuchi S.

Publication type:

Article

Locally acting ACE-083 increases muscle volume in healthy volunteers.

Published in:

2018

By:

Glasser, Chad E.;
Gartner, Michael R.;
Wilson, Dawn;
Miller, Barry;
Sherman, Matthew L.;
Attie, Kenneth M.

Publication type:

journal article

Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial.

Published in:

2017

By:

Campbell, Craig;
McMillan, Hugh J.;
Mah, Jean K.;
Tarnopolsky, Mark;
Selby, Kathryn;
McClure, Ty;
Wilson, Dawn M.;
Sherman, Matthew L.;
Escolar, Diana;
Attie, Kenneth M.

Publication type:

journal article

A single ascending-dose study of muscle regulator ace-031 in healthy volunteers.

Published in:

Muscle & Nerve, 2013, v. 47, n. 3, p. 416, doi. 10.1002/mus.23539

By:

Attie, Kenneth M.;
Borgstein, Niels G.;
Yang, Yijun;
Condon, Carolyn H.;
Wilson, Dawn M.;
Pearsall, Amelia E.;
Kumar, Ravi;
Willins, Debbie A.;
Seehra, Jas S.;
Sherman, Matthew L.

Publication type:

Article

Sotatercept in patients with osteolytic lesions of multiple myeloma.

Published in:

British Journal of Haematology, 2014, v. 165, n. 6, p. 814, doi. 10.1111/bjh.12835

By:

Abdulkadyrov, Kudrat M.;
Salogub, Galina N.;
Khuazheva, Nuriet K.;
Sherman, Matthew L.;
Laadem, Abderrahmane;
Barger, Rachel;
Knight, Robert;
Srinivasan, Shankar;
Terpos, Evangelos

Publication type:

Article

The Role for Interleukin-12 Therapy of Cutaneous T Cell Lymphoma.

Published in:

Annals of the New York Academy of Sciences, 2001, v. 941, n. 1, p. 177, doi. 10.1111/j.1749-6632.2001.tb03721.x

By:

ROOK, ALAIN H.;
ZAKI, MOHAMED H.;
WYSOCKA, MARIA;
WOOD, GARY S.;
DUVIC, MADELEINE;
SHOWE, LOUISE C.;
FOSS, FRANCINE;
SHAPIRO, MICHAEL;
KUZEL, TIMOTHY M.;
OLSEN, ELISE A.;
VONDERHEID, ERIC C.;
LALIBERTE, ROBERT;
SHERMAN, MATTHEW L.

Publication type:

Article

Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies.

Published in:

2016

By:

Raftopoulos, Haralambos;
Glaspy, John;
Crawford, Jeffrey;
Laadem, Abderrahmane;
Puccio-Pick, Marie;
Zou, Jun;
Hesketh, Paul;
Goldschmidt, Jerome;
Gabrail, Nashat;
Osborne, Cynthia;
Ali, Muhammad;
Sherman, Matthew;
Wang, Ding;
Hesketh, Paul J;
Sherman, Matthew L;
Glaspy, John A

Publication type:

journal article

A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2003, v. 52, n. 4, p. 243, doi. 10.1007/s00262-002-0343-x

By:

Chan, Stephen Y.;
Gordon, Alan N.;
Coleman, Robert E.;
Hall, James B.;
Berger, Mark S.;
Sherman, Matthew L.;
Eten, Catharine B.;
Finkler, Neil J.

Publication type:

Article

A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers.

Published in:

American Journal of Hematology, 2014, v. 89, n. 7, p. 766, doi. 10.1002/ajh.23732

By:

Attie, Kenneth M.;
Allison, Mark J.;
McClure, Ty;
Boyd, Ingrid E.;
Wilson, Dawn M.;
Pearsall, Amelia E.;
Sherman, Matthew L.

Publication type:

Article

Biological Consequences of Gene Regulation After Ionizing Radiation Exposure.

Published in:

JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 7, p. 480

By:

Weichselbaum, Ralph R.;
Hallahan, Dennis E.;
Sukhatme, Vikas;
Dritschilo, Anatoly;
Sherman, Matthew L.;
Kufe, Donald W.

Publication type:

Article

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study2.

Published in:

JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 13, p. 1039

By:

Spriggs, David R.;
Sherman, Matthew L.;
Michie, Hamish;
Arthur, Kristina A.;
Imamura, Kyoko;
Wilmore, Douglas;
Frei, Emil;
Kufe, Donald W.

Publication type:

Article